# Effectiveness of Bisacodyl Suppository Agent for Dose Reduction of Low Dose PEG

> **NCT03849196** · NA · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 168 (actual)

## Conditions studied

- Bowel Preparation

## Interventions

- **DRUG:** 2L PEG-Asc
- **DRUG:** Bisacodyl 10Mg Suppository
- **DRUG:** 1L PEG-Asc

## Key facts

- **NCT ID:** NCT03849196
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-31
- **Primary completion:** 2018-01-30
- **Final completion:** 2018-01-30
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2019-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03849196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03849196, "Effectiveness of Bisacodyl Suppository Agent for Dose Reduction of Low Dose PEG". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03849196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*